Physician profile
Ayesha Khalid
NPI 1528285921
$511,482.98
in general payments reported to CMS, 2019-2025
10 companies · $314K in 2025
The $314K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2021: $2,279 · 2022: $3,038 · 2023: $49K · 2024: $143K · 2025: $314K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $264K · Consulting Fee: $200K · Travel and Lodging: $36K · Food and Beverage: $5,749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $264,380.00 |
| Consulting Fee | $199,658.75 |
| Travel and Lodging | $36,241.82 |
| Food and Beverage | $5,749.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $160,989.37 | 2019-2025 | Scopis Ent, Latera, Clarifix |
| Regeneron Healthcare Solutions, INC. | $156,508.45 | 2022-2025 | Dupixent |
| Genzyme Corporation | $150,820.04 | 2023-2025 | |
| Medtronic, INC. | $40,575.47 | 2022-2025 | Propel, Endo-Scrub, Straightshot |
| Intersect Ent, INC. | $2,276.39 | 2019-2021 | |
| Inspire Medical Systems, INC. | $136.96 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $65.58 | 2019 | |
| Neurent Medical Limited | $57.72 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Ethicon US, LLC | $31.68 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $21.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayesha Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.